Delivery Order SPE2DX22D0010-SPE2D826FBN37
Award Date 12/5/25
Potential Completion Date 12/8/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Quillivant XR Oral Suspension (60ML, 5MG/ML), an FDA-approved medication for attention-deficit/hyperactivity disorder treatment. This firm fixed-price delivery order, valued at $6,709.14, represents a non-competitive set-aside contract with an ultimate completion date of November 10, 2025. The product will be delivered to AmerisourceBergen's location...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML, a pharmaceutical product used in the treatment of attention deficit disorders. The award, valued at $9,205.46, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Quillivant XR Oral Suspension 60ml 5mg/ml, a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This competitively awarded, non-set-aside delivery order carries a ceiling value of $8,807.10 with firm fixed pricing and an ultimate completion date of August 14, 2025. The contract is performed out of...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency valued at $1,736.54 for Quillivant XR 25 mg/5 mL suspension (120 mL), a medication commonly prescribed for attention-deficit/hyperactivity disorder. The contract is not set-aside, indicating it was awarded through open competition. The delivery order carries a firm fixed price structure with an ultimate completion date of December 5, 2025, and will be performed at AmerisourceBergen's facility in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for Quillivant XR 25 mg/5 ml suspension (60 ml), valued at $2,361.84, with an ultimate completion date of November 5, 2025. This is a firm fixed price, non-set-aside contract representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,072.26 to AmerisourceBergen Drug Corp for Quillivant XR Oral Suspension 120ML 5MG/ML, a pharmaceutical product used in the treatment of attention-deficit/hyperactivity disorder. The contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, was issued as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 1, 2025, for Quillivant XR 25 mg/5 mL suspension (120 mL) with a ceiling value of $1,615.19. This firm fixed-price delivery order is set to be completed by December 2, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, for Quillivant XR 25 mg/5 mL suspension (60 mL), with a ceiling value of $3,154.08. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 27, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,274.31 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (60 ml), a pharmaceutical product used in treating attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL), a pharmaceutical product used to treat attention deficit hyperactivity disorder. The contract is a firm fixed-price delivery order with a ceiling value of $3,893.03 and an ultimate completion date of November 26, 2025. This award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's...